Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Gillett

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Mayo Clinic Proceedings|December 15, 2004
Tissue ablation technologies for localized prostate cancerMichael D Gillett, Matthew T Gettman, Horst Zincke, et al.
BJU International|August 18, 2005
Should the upper tracts be imaged for microscopic haematuria?Murray S Feldstein, Joseph G Hentz, Michael D Gillett, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|September 22, 2006
Case report: intraoperative anaphylactoid reaction and hydroxyethyl starch in balanced electrolyte solution (Hextend)Brian A Hall, Evangelo Frigas, Damir Matesic, et al.
The Journal of Urology|January 12, 2005
Split-thickness skin graft for the management of concealed penisMichael D Gillett, Suzanne R Rathbun, Douglas A Husmann, et al.
The Journal of Urology|December 14, 2007
Differences in organ system of distant metastasis by renal cell carcinoma subtypeNathan E Hoffmann, Michael D Gillett, John C Cheville, et al.
The Journal of Urology|May 10, 2005
Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal massesMichael D Gillett, John C Cheville, R Jeffrey Karnes, et al.
Cancer|October 7, 2005
Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinomaR Houston Thompson, Michael D Gillett, John C Cheville, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2004
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic targetR Houston Thompson, Michael D Gillett, John C Cheville, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Mayo Clinic Proceedings|December 15, 2004
Tissue ablation technologies for localized prostate cancerMichael D Gillett, Matthew T Gettman, Horst Zincke, et al.
BJU International|August 18, 2005
Should the upper tracts be imaged for microscopic haematuria?Murray S Feldstein, Joseph G Hentz, Michael D Gillett, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|September 22, 2006
Case report: intraoperative anaphylactoid reaction and hydroxyethyl starch in balanced electrolyte solution (Hextend)Brian A Hall, Evangelo Frigas, Damir Matesic, et al.
The Journal of Urology|January 12, 2005
Split-thickness skin graft for the management of concealed penisMichael D Gillett, Suzanne R Rathbun, Douglas A Husmann, et al.
The Journal of Urology|December 14, 2007
Differences in organ system of distant metastasis by renal cell carcinoma subtypeNathan E Hoffmann, Michael D Gillett, John C Cheville, et al.
The Journal of Urology|May 10, 2005
Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal massesMichael D Gillett, John C Cheville, R Jeffrey Karnes, et al.
Cancer|October 7, 2005
Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinomaR Houston Thompson, Michael D Gillett, John C Cheville, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2004
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic targetR Houston Thompson, Michael D Gillett, John C Cheville, et al.
Pageof 1